Cerebral small vessel disease burden for bleeding risk during antithrombotic therapy: Bleeding with Antithrombotic Therapy 2 study.
Kanta TanakaKaori MiwaMasatoshi KogaSohei YoshimuraKenji KamiyamaYoshiki YagitaYoshinari NagakaneHaruhiko HoshinoTadashi TerasakiYasushi OkadaYusuke YakushijiShinichi TakahashiToshihiro UedaYasuhiro HasegawaMasayuki ShiozawaMakoto SasakiKohsuke KudoJun TanakaMasashi NishiharaYoshitaka YamaguchiKyohei FujitaYuko HondaHiroyuki KawanoToshihiro IdeTakeshi YoshimotoMasafumi IharaTeruyuki HiranoKazunori Toyodanull nullPublished in: Annals of neurology (2023)
Total SVD score was predictive for intracranial hemorrhage and probably for extracranial bleeding, suggesting the broader clinical relevance of cerebral SVD as a marker for safe implementation of antithrombotic therapy. This article is protected by copyright. All rights reserved.